Ahmet Uluer, DO, MPH
Director, BRIDGES Adult Transition Program; Director, Adult Cystic Fibrosis Program
Assistant Professor of Pediatrics, Harvard Medical School
Image
Ahmet Uluer, DO, MPH
Director, BRIDGES Adult Transition Program; Director, Adult Cystic Fibrosis Program
Assistant Professor of Pediatrics, Harvard Medical School
Medical Services
Languages
English
Education
Undergraduate School
University of Michigan
1991
Ann Arbor
MI
Medical School
Kansas City University of Medicine and Biosciences
1999
Kansas City
MO
Internship
Internal Medicine and Pediatrics
Cleveland Clinic
Cleveland
OH
Residency
Internal Medicine and Pediatrics
Cleveland Clinic
Cleveland
OH
Fellowship
Pulmonary Medicine
Boston Children's Hospital
2006
Boston
MA
Media
Parentcast Podcast
Dr. Ahmet Uluer is featured: Should I transition my teen to an adult provider?
Certifications
American Board of Internal Medicine (General)
Publications
Sepsis beyond bundles: contextualising paediatric care in resource-limited settings through situational analysis. View Abstract
Contraceptive use and pregnancy in cystic fibrosis: Survey findings from 10 cystic fibrosis centers. View Abstract
Cystic Fibrosis Experience of Care Survey: Patient-Caregiver-Clinician Collaborative Design and Implementation. View Abstract
Impact of Cystic Fibrosis Transmembrane Conductance Regulator Modulators on Maternal Outcomes During and After Pregnancy. View Abstract
Safety and tolerability of a low glycemic load dietary intervention in adults with cystic fibrosis: a pilot study. View Abstract
Health care transition quadruple aim outcomes for IDD: Scoping review. View Abstract
Healthcare transition readiness of families of youth with cystic fibrosis during COVID-19: A correlational multicenter analysis. View Abstract
Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF. View Abstract
De novo mutations mediate phenotypic switching in an opportunistic human lung pathogen. View Abstract
Randomized Trial of the Insulin-Only iLet Bionic Pancreas for the Treatment of Cystic Fibrosis- Related Diabetes. View Abstract
Cystic fibrosis-related mortality in the United States from 1999 to 2020: an observational analysis of time trends and disparities. View Abstract
Development and Validation of a Respiratory-Responsive Vocal Biomarker-Based Tool for Generalizable Detection of Respiratory Impairment: Independent Case-Control Studies in Multiple Respiratory Conditions Including Asthma, Chronic Obstructive Pulmonary Disease, and COVID-19. View Abstract
Association between unplanned pregnancies and maternal exacerbations in cystic fibrosis. View Abstract
Safety and efficacy of vanzacaftor-tezacaftor-deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials. View Abstract
Continuous Glucose Monitoring and HbA1c in Cystic Fibrosis: Clinical Correlations and Implications for CFRD Diagnosis. View Abstract
The Relationship between Body Composition, Dietary Intake, Physical Activity, and Pulmonary Status in Adolescents and Adults with Cystic Fibrosis. View Abstract
Issues affecting young people with asthma through the transition period to adult care. View Abstract
Empire-CF study: A phase 2 clinical trial of leukotriene A4 hydrolase inhibitor acebilustat in adult subjects with cystic fibrosis. View Abstract
The effect of elexacaftor/tezacaftor/ivacaftor (ETI) on glycemia in adults with cystic fibrosis. View Abstract
Favorable Clinician Acceptability of Telehealth as Part of the Cystic Fibrosis Care Model during the COVID-19 Pandemic. View Abstract
Family-building and parenting considerations for people with cystic fibrosis. View Abstract
The Effects of Ivacaftor on Bone Density and Microarchitecture in Children and Adults with Cystic Fibrosis. View Abstract
Men's health in the modern era of cystic fibrosis. View Abstract
Integration of mental health screening and treatment into cystic fibrosis clinics: Evaluation of initial implementation in 84 programs across the United States. View Abstract
Supporting the Medically Fragile: Individualized Approach to Empowering Young Adults With Chronic Disease During the COVID-19 Pandemic. View Abstract
Children's Hospitals Caring for Adults During a Pandemic: Pragmatic Considerations and Approaches. View Abstract
Prevalence and clinical associations of Staphylococcus aureus small-colony variant respiratory infection in children with cystic fibrosis (SCVSA): a multicentre, observational study. View Abstract
Antifibrinolytic Agents for Hemoptysis Management in Adults With Cystic Fibrosis. View Abstract
VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles. View Abstract
Sexual and Reproductive Health of Young Women With Cystic Fibrosis: A Concept Mapping Study. View Abstract
A Pilot Study of Inspiratory Muscle Training to Improve Exercise Capacity in Patients with Fontan Physiology. View Abstract
Overcoming barriers to a successful transition from pediatric to adult care. View Abstract
Impact of CFTR Modulation on Intestinal pH, Motility, and Clinical Outcomes in Patients With Cystic Fibrosis and the G551D Mutation. View Abstract
Comparison of Nasal Potential Difference and Intestinal Current Measurements as Surrogate Markers for CFTR Function. View Abstract
Young adults with cystic fibrosis have altered trabecular microstructure by ITS-based morphological analysis. View Abstract
Risk Factors for Hearing Loss in Patients with Cystic Fibrosis. View Abstract
Correlations of salivary biomarkers with clinical assessments in patients with cystic fibrosis. View Abstract
Trends in bone mineral density in young adults with cystic fibrosis over a 15 year period. View Abstract
Compromised bone microarchitecture and estimated bone strength in young adults with cystic fibrosis. View Abstract
An automated integrated platform for rapid and sensitive multiplexed protein profiling using human saliva samples. View Abstract
Inhaled amiloride and tobramycin solutions fail to eradicate Burkholderia dolosa in patients with cystic fibrosis. View Abstract
Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. View Abstract
Employment experiences among adolescents and young adults with cystic fibrosis. View Abstract
A safe protocol for rapid desensitization in patients with cystic fibrosis and antibiotic hypersensitivity. View Abstract
Sensorineural hearing loss in patients with cystic fibrosis. View Abstract
Recovery of Herbaspirillum species from persons with cystic fibrosis. View Abstract
Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis. View Abstract
Polymerase chain reaction/denaturing gradient gel electrophoresis (PCR/DGGE): sensitivity, band pattern analysis, and methodologic optimization. View Abstract
High-affinity agonist binding is not sufficient for agonist efficacy at 5-hydroxytryptamine2A receptors: evidence in favor of a modified ternary complex model. View Abstract
5-Hydroxytryptamine2A (5-HT2A) receptor desensitization can occur without down-regulation. View Abstract
Lymphomatoid papulosis and associated cutaneous lymphoproliferative disorders exhibit a common clonal origin. View Abstract
Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding. View Abstract
Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. View Abstract